Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.102 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.124 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.46.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.33NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.5.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.75.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.1.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CR.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DV.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.57NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.49NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.69NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.60NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.24 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.45 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.70 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.26.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.108 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.32 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.46.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.6 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
AY.75.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.37 (Lambda)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BT.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FS.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.5.54NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
N.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.15 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.348NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.575NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.4 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.442NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.1 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.2.5.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used